Your session is about to expire
← Back to Search
MucoLox for Mucositis in Head/Neck Cancer
Study Summary
This trial will study if MucoLox can prevent severe mucositis in head/neck cancer patients receiving radiation and/or chemotherapy.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I can swish and spit medicine as my doctor thinks is okay.I haven't taken any drugs for mouth sores in the last week, except for certain allowed ones.I am mostly able to care for myself and carry out daily activities.I do not have any mouth, throat, or dental issues that could affect the study.I am 18 years old or older.I have head or neck cancer and will undergo radiation for at least 28 days.I am on long-term medication to suppress my immune system.I do not have any untreated mouth infections.I have moderate to severe mouth sores.
- Group 1: A
- Group 2: B
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many human participants are included in this clinical experiment?
"Affirmative. According to the records found on clinicaltrials.gov, this medical trial opened for recruitment on March 15th 2018 and is still ongoing today. The study requires 60 patients from 1 location."
Are recruitments for this research protocol still taking place?
"Affirmative. Clinicaltrials.gov attests that this medical trial is open for recruitment, with the original post date being 15th March 2018 and updates made on 10th September 2022. Sixty volunteers are currently required at a single research centre."
Are there any existing precedents for MucoLox experimentation?
"At present, there are 20 ongoing clinical studies examining the efficacy of MucoLox with 1 in Phase 3. The hub for these investigations is Decatur, Georgia but research sites span across 29 locations nationwide."
What conditions is MucoLox employed to treat?
"MucoLox is typically prescribed for barbiturate treatment, but it can also provide relief to patients with helicobacter infections, acute diarrhea and dental plaque."
Share this study with friends
Copy Link
Messenger